We are live on ! Find out more
CFA

Camarda Financial Advisors Portfolio holdings

AUM $190M
1-Year Est. Return 48.71%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+48.71%
3 Year Est. Return
+132.11%
5 Year Est. Return
+247.64%
10 Year Est. Return
+511.39%
AUM
$146M
AUM Growth
+$15.5M
Cap. Flow
+$8.33M
Cap. Flow %
5.71%
Top 10 Hldgs %
38.14%
Holding
245
New
42
Increased
60
Reduced
53
Closed
25

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$468K
2
AAPL icon
Apple
AAPL
+$349K
3
M icon
Macy's
M
+$319K
4
GLOG
GASLOG LTD
GLOG
+$307K
5
BAC icon
Bank of America
BAC
+$221K

Sector Composition

Rank Sector Weight
1 Healthcare 12.37%
2 Energy 6.72%
3 Industrials 5.18%
4 Technology 4.65%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FL
51
DELISTED
Foot Locker
FL
$502K 0.34%
9,890
-3,085
-24% -$148K
TARO
52
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$485K 0.33%
3,455
-844
-20% -$93.7K
ICON
53
DELISTED
Iconix Brand Group, Inc.
ICON
$471K 0.32%
1,098
-317
-22% -$131K
EVRI
54
DELISTED
Everi Holdings
EVRI
$462K 0.32%
51,929
-11,661
-18% -$92.6K
COP icon
55
ConocoPhillips
COP
$144B
$439K 0.3%
5,125
+3,625
+242% +$282K
GPOR
56
DELISTED
Gulfport Energy Corp.
GPOR
$435K 0.3%
6,925
-1,900
-22% -$127K
ET icon
57
Energy Transfer Partners
ET
$69.5B
$418K 0.29%
14,172
+8,230
+139% +$208K
MTSC
58
DELISTED
MTS Systems Corp
MTSC
$410K 0.28%
6,046
-1,513
-20% -$101K
LMT icon
59
Lockheed Martin
LMT
$131B
$406K 0.28%
2,527
+1,271
+101% +$207K
ALG icon
60
Alamo Group
ALG
$1.91B
$399K 0.27%
7,380
-1,912
-21% -$102K
CACI icon
61
CACI
CACI
$10.8B
$397K 0.27%
5,649
-1,357
-19% -$96.3K
MO icon
62
Altria Group
MO
$125B
$394K 0.27%
9,387
+5,389
+135% +$217K
USNA icon
63
Usana Health Sciences
USNA
$419M
$394K 0.27%
10,072
-2,366
-19% -$87.8K
IWC icon
64
iShares Micro-Cap ETF
IWC
$1.42B
$388K 0.27%
5,091
+1,011
+25% +$74.1K
ROST icon
65
Ross Stores
ROST
$80.8B
$384K 0.26%
11,628
-2,716
-19% -$93.2K
CA
66
DELISTED
CA, Inc.
CA
$368K 0.25%
12,816
-2,866
-18% -$84.8K
UIS icon
67
Unisys
UIS
$252M
$363K 0.25%
14,661
-3,154
-18% -$79.7K
EPD icon
68
Enterprise Products Partners
EPD
$83.7B
$352K 0.24%
8,994
+5,892
+190% +$217K
RAI
69
DELISTED
Reynolds American Inc
RAI
$351K 0.24%
11,638
+7,664
+193% +$220K
LO
70
DELISTED
LORILLARD INC COM STK
LO
$348K 0.24%
5,706
+3,591
+170% +$209K
KMP
71
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$341K 0.23%
4,150
+2,856
+221% +$220K
SUI icon
72
Sun Communities
SUI
$15.8B
$340K 0.23%
6,825
+4,714
+223% +$222K
SDRL
73
DELISTED
Seadrill Limited Common Stock
SDRL
$340K 0.23%
32
+24
+300% +$234K
NC icon
74
NACCO Industries
NC
$359M
$339K 0.23%
29,304
-5,703
-16% -$68.9K
LLY icon
75
Eli Lilly
LLY
$1.08T
$338K 0.23%
5,441
+3,557
+189% +$212K

Similar funds

Camarda Financial Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Camarda Financial Advisors held 245 positions worth $146M, up 12% from $130M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Camarda Financial Advisors deployed $8.33M of net new capital in Q2 2014, opening 42 new positions and adding to 60 existing holdings. Its largest new stake was Bristol-Myers Squibb: 21,261 shares worth $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $468K trimmed.

  • Camarda Financial Advisors's largest Q2 2014 buy was Bristol-Myers Squibb: 21,261 shares worth $1.03M.
  • Camarda Financial Advisors added most to iShares Frontier and Select EM ETF in Q2 2014, an estimated $3.06M increase.
  • Camarda Financial Advisors's biggest Q2 2014 reduction was Amgen, cutting an estimated $468K.
  • Camarda Financial Advisors fully exited Macy's in Q2 2014, selling an estimated $319K.
  • Camarda Financial Advisors's ten largest holdings make up 38% of its $146M portfolio in Q2 2014.
  • Camarda Financial Advisors opened 42 new positions and closed 25 in Q2 2014.
  • Camarda Financial Advisors's portfolio value rose 12% quarter-over-quarter to $146M.

Based on Camarda Financial Advisors's 13F filing for Q2 2014, filed 11 Jul 2014.